Concerns about chronic traumatic encephalopathy, often called CTE, have grown rapidly over the past decade. Former football players, boxers, soccer athletes, and military veterans have all been part of the public conversation around repetitive head injuries and long-term brain health. Now, a new study published in Nature Medicine suggests that current clinical criteria used to diagnose traumatic encephalopathy syndrome, or TES, may not accurately predict whether someone truly has CTE-related brain changes.
The findings are raising important questions for athletes, healthcare providers, and researchers who are trying to better understand the relationship between head trauma, memory decline, mood changes, and neurodegenerative disease.
Chronic traumatic encephalopathy is a brain condition linked to repeated head impacts. Scientists believe it develops after years of repetitive trauma, especially in contact sports such as American football, boxing, hockey, and soccer.
However, one major challenge remains. CTE can only be officially diagnosed after death through a postmortem examination of brain tissue. Researchers look for a unique buildup of abnormal tau protein around blood vessels deep in the folds of the brain.
Because doctors cannot yet confirm CTE in living patients, researchers developed clinical guidelines known as traumatic encephalopathy syndrome. TES was designed to help identify people who may have underlying CTE based on symptoms and exposure history.
The study reviewed medical records and brain tissue from 1,038 individuals in a neurodegenerative disease brain bank at the University of Pennsylvania. Researchers examined whether TES criteria accurately predicted the presence of CTE-related brain pathology.
Out of all participants, only 25 individuals met the diagnostic criteria for TES. Yet just six of those cases actually showed CTE-related brain changes during neuropathological examination.
That means the positive predictive value of TES was only 24 percent. In simple terms, most people who met the clinical criteria for TES did not have confirmed CTE pathology.
Researchers also discovered that the strongest predictor was not the symptoms themselves, but simply whether a person had experienced repetitive head impacts.
Another major finding was that common TES symptoms were also frequently seen in people without CTE.
The study examined symptoms such as:
Researchers found no major difference in these symptoms between individuals with confirmed CTE pathology and a matched comparison group without documented head trauma.
This suggests that many symptoms currently associated with TES may overlap with other neurological or psychiatric conditions, including Alzheimer’s disease, depression, or normal aging.
Public awareness around CTE has exploded in recent years, especially among former professional athletes. Many retired players fear that memory problems, mood swings, or concentration issues may signal irreversible brain disease.
The study authors warned that inaccurate diagnoses may create unnecessary psychological distress. Some individuals may believe they have a progressive neurodegenerative disorder when their symptoms could actually be caused by treatable conditions such as depression, anxiety, sleep disorders, or other medical issues.
Researchers specifically highlighted concerns about a possible nocebo effect. This occurs when fear and expectation of illness worsen emotional and physical symptoms.
The current TES criteria were introduced in 2019 by experts convened through the U.S. National Institute of Neurological Disorders and Stroke. However, the criteria have remained controversial from the beginning.
Critics argue that the symptoms are too broad and not unique enough to distinguish CTE from other neurological diseases. Supporters believe the framework is still useful for research while scientists search for better biomarkers and imaging techniques.
This latest research adds significant weight to the argument that TES may not yet be ready for widespread clinical use.
Importantly, the researchers emphasized that current TES guidelines were intended primarily for research settings, not routine medical diagnosis.
Although the study raises concerns about current diagnostic methods, it does not dismiss the existence of CTE.
The researchers confirmed that CTE-related brain changes were more common in people with repetitive head trauma histories, particularly former contact sport athletes. However, the study suggests scientists still do not fully understand:
Many individuals with confirmed CTE pathology also had additional brain diseases present at the same time. This overlap makes it difficult to determine which symptoms are caused by which condition.
Researchers say future progress will depend on long-term studies that follow athletes and other at-risk individuals during life and compare findings with postmortem examinations later.
Scientists are also working to develop biomarkers, blood tests, and brain imaging tools that may eventually help detect CTE in living patients more accurately.
Until then, experts caution against assuming that mood changes or cognitive symptoms automatically indicate CTE.
Healthcare professionals are encouraged to evaluate other possible explanations, many of which may be treatable or manageable with proper care.
This new study highlights a critical challenge in modern brain injury research. While concern about repeated head trauma is justified, diagnosing CTE during life remains highly uncertain.
The findings suggest that current TES criteria may overestimate the likelihood of CTE and could potentially lead to unnecessary fear among former athletes and others exposed to repeated head impacts.
Researchers continue to stress the importance of better diagnostic tools, stronger evidence, and careful communication with patients who may already be worried about long-term brain health.
Arena JD, Stewart W, Schneider ALC, et al. “Performance of traumatic encephalopathy syndrome criteria in identifying individuals with chronic traumatic encephalopathy.” Published in Nature Medicine on May 14, 2026.
This article is for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Individuals experiencing cognitive, emotional, or neurological symptoms should consult a qualified healthcare professional for proper evaluation and care.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.